BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $349,000 | -24.1% | 6,600 | -12.0% | 0.00% | -100.0% |
| Q2 2020 | $460,000 | +23.3% | 7,500 | +13.6% | 0.00% | 0.0% |
| Q1 2020 | $373,000 | -0.8% | 6,600 | 0.0% | 0.00% | – |
| Q4 2019 | $376,000 | +6.5% | 6,600 | 0.0% | 0.00% | – |
| Q3 2019 | $353,000 | -37.0% | 6,600 | -29.7% | 0.00% | -100.0% |
| Q2 2019 | $560,000 | -4.3% | 9,384 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $585,000 | +46.2% | 9,384 | +42.2% | 0.00% | 0.0% |
| Q4 2018 | $400,000 | +3.6% | 6,600 | 0.0% | 0.00% | – |
| Q3 2018 | $386,000 | +30.4% | 6,600 | 0.0% | 0.00% | – |
| Q2 2018 | $296,000 | -12.2% | 6,600 | -13.1% | 0.00% | – |
| Q1 2018 | $337,000 | -16.4% | 7,597 | -18.4% | 0.00% | – |
| Q4 2017 | $403,000 | -16.0% | 9,310 | -9.8% | 0.00% | -100.0% |
| Q3 2017 | $480,000 | -47.7% | 10,318 | -44.3% | 0.00% | 0.0% |
| Q2 2017 | $917,000 | +5.6% | 18,519 | +16.9% | 0.00% | 0.0% |
| Q1 2017 | $868,000 | +4.0% | 15,838 | +5.7% | 0.00% | 0.0% |
| Q4 2016 | $835,000 | +51.0% | 14,986 | +23.7% | 0.00% | 0.0% |
| Q3 2016 | $553,000 | +29.2% | 12,119 | +13.1% | 0.00% | 0.0% |
| Q2 2016 | $428,000 | +3.9% | 10,719 | -9.4% | 0.00% | 0.0% |
| Q1 2016 | $412,000 | +8.4% | 11,825 | +33.9% | 0.00% | 0.0% |
| Q4 2015 | $380,000 | -1.3% | 8,833 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $385,000 | -8.3% | 8,833 | +8.6% | 0.00% | 0.0% |
| Q2 2015 | $420,000 | +195.8% | 8,133 | +123.9% | 0.00% | – |
| Q1 2015 | $142,000 | – | 3,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|